Fidelity Nasdaq Composite Index ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.21
資產淨值: 99.09
成立日期: 25/09/2003
 
分析
市值分佈:
98.30%
大市值
1.95%
中市值
0.21%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:06) 總持有投資項目: 1005  
0%
 
100%
     10大 (56.46%)
代號 名稱 佔比% ▼ 持有日期
BBNXBeta Bionics Inc0.00330/10/2026
AVLNAvalyn Pharma Inc0.00330/10/2026
CRVSCorvus Pharmaceuticals0.00330/10/2026
VORVor Biopharma Inc0.00330/10/2026
QMCOQuantum Corp0.00330/10/2026
FCELFuelCell Energy Inc0.00330/10/2026
SGMLSigma Lithium Corp0.00230/10/2026
NNBRNN0.00230/09/2026
HIMXHimax Technologies0.00230/10/2026
OBXObsidian Therapeutics Inc0.00230/10/2026
EMATEvolution Metals & Technologies Corp.0.00230/10/2026
GLUEMonte Rosa Therapeutics0.00230/10/2026
SANASana Biotechnology0.00230/10/2026
ALMSAlumis Inc.0.00230/10/2026
HMPT--0.00228/07/2023
GILTGilat Satellite Networks Ltd0.00230/10/2026
SHAZSharonAI Holdings, Inc.0.00230/10/2026
BCAXBicara Therapeutics Inc.0.00230/10/2026
FLNCFluence Energy0.00230/10/2026
OCSOculis Holding AG0.00230/10/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20    21    22    23    24    25    26    27    28    29    30    31    32    33    34    35    36    37    38    39    40    41    42    43    44    45    46    47    48   49    50    51  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.